Our Stem Cell Capabilities
The REPROCELL (Stemgent) brand is well known in the global stem cell research community. The brand has become associated with stem cell performance-qualified reagents and innovation after becoming the first company to launch an mRNA reprogramming kit for making iPSCs. Today, the organization is armed with broader capabilities and expertise and has recently developed a third-generation reprogramming technology (StemRNA 3rd Gen RNA Reprogramming) which is now available through iPSC reprogramming services. All of this, combined with complementary REPROCELL know-how from across the globe, uniquely positions the organization with a full-range of iPSC services including iPSC reprogramming, Neuronal differentiation, iPSC expansion, characterization, and banking.
Stemgent’s customers include pharmaceutical and biotechnology companies, as well as top academic and government research institutions from all around the globe. Reprogramming technology and iPSC usage can also be made available for a variety of commercial applications with licenses available through REPROCELL. We wleocme applications from ambitious individuals from a range of backgrounds, but in particular scientists with a background in commercial contract research, large pharma, pharmacology/physiology or preclinical and safety pharmacology drug discovery.